Clinical Intervention Psychosis and Addiction

Early Phase 1UnknownNCT01411566

University of Cologne122 enrolled

Overview

The purpose of this study is to evaluate an integrative therapeutic concept for schizophrenic patients with comorbid substance use disorder.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

122

Conditions

Psychosis Substance Abuse

Interventions

Skills trainig for patients with dual diagnosisBEHAVIORAL

Skills trainig for patients with dual diagnosis

regular treatmentBEHAVIORAL

regular treatment

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Schizophrenia * Addiction * Written statement of agreement * Majority Exclusion Criteria: * Acute psychosis * Further neuropsychiatric disorder

Locations (1)

LVR Clinic Cologne - Academic Clinic of the University of Cologne

Cologne, Germany

RECRUITING

Outcomes

Primary Outcomes

Substance use

Time frame: one year

Substance use

Time frame: 3 months

Substance use

Time frame: 6 months

Change in drug use motivation

Time frame: 3 months

Change in drug use motivation

Time frame: 6 months

Change in drug use motivation

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.